N
BIVV

Nuveen’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Nuveen’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-430,000
Closed -$23.2M – 1178
2017
Q4 		$23.2M Buy
430,000
+311,223
+262% +$17M 0.15% 205
2017
Q3 		$6.78M Buy
+118,777
New +$6.96M 0.04% 451
2017
Q2 		– Sell
-32,238
Closed -$1.76M – 1407
2017
Q1 		$1.76M Buy
+32,238
New +$1.59M 0.01% 740

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Nuveen's BIVV Position: Q1 2018 in Review

Nuveen sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 430,000 shares — an estimated $23.2M sold.

Nuveen first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $23.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Nuveen reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Nuveen sold 430,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $23.2M.
  • Nuveen first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • Nuveen's Bioverativ Inc. Common Stock position peaked at $23.2M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Nuveen's 13F filing for Q1 2018, filed 14 May 2018.